Publications
Number
Publication
Language
Animal Welfare Report 2022
Interpharma members are constantly working to develop new research methods and to minimise the number of laboratory animals. However, animal experiments remain essential for researching ubiquitous diseases such as cancer, multiple sclerosis and Alzheimer’s disease, and in developing new treatments. It is therefore important that pharmaceutical companies give top priority to responsible animal use and actively implement the 10-point Animal Welfare Charter adopted by member companies of Interpharma in 2010.
Animal Welfare Report 2022
Pharma Location Switzerland
MFN: Looking forward
MFN is already affecting Switzerland: companies are delaying or pausing launches. Low Swiss prices remain a strategic vulnerability beyond 2029, so Switzerland should prepare now.
MFN: Looking forward